These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28662149)

  • 1. In vitro additive interaction between ketoconazole and antimony against intramacrophage Leishmania (Leishmania) amazonensis amastigotes.
    Nunes DCO; Bispo-da-Silva LB; Napolitano DR; Costa MS; Figueira MMNR; Rodrigues RS; Rodrigues VM; Yoneyama KAG
    PLoS One; 2017; 12(6):e0180530. PubMed ID: 28662149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2'-Hydroxyflavanone activity in vitro and in vivo against wild-type and antimony-resistant Leishmania amazonensis.
    Gervazoni LFO; Gonçalves-Ozório G; Almeida-Amaral EE
    PLoS Negl Trop Dis; 2018 Dec; 12(12):e0006930. PubMed ID: 30521527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. M1 homeopathic complex trigger effective responses against Leishmania (L) amazonensis in vivo and in vitro.
    Nascimento KF; de Santana FR; da Costa CRV; Kaplum V; Volpato H; Nakamura CV; Bonamin LV; de Freitas Buchi D
    Cytokine; 2017 Nov; 99():80-90. PubMed ID: 28738234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of clinically sensitive and resistant Leishmania to pentavalent antimony in vitro.
    Berman JD; Chulay JD; Hendricks LD; Oster CN
    Am J Trop Med Hyg; 1982 May; 31(3 Pt 1):459-65. PubMed ID: 7081539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to antimony and treatment failure in human Leishmania (Viannia) infection.
    Rojas R; Valderrama L; Valderrama M; Varona MX; Ouellette M; Saravia NG
    J Infect Dis; 2006 May; 193(10):1375-83. PubMed ID: 16619185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro interaction between SURFACEN® and surfactant protein A against Leishmania amazonensis.
    de Guevara YL; Hidalgo OB; Faure R; Fidalgo LM
    Chemotherapy; 2013; 59(4):247-50. PubMed ID: 24401208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
    Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
    Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-administration of glycyrrhizic acid with the antileishmanial drug sodium antimony gluconate (SAG) cures SAG-resistant visceral leishmaniasis.
    Bhattacharjee A; Majumder S; Majumdar SB; Choudhuri SK; Roy S; Majumdar S
    Int J Antimicrob Agents; 2015 Mar; 45(3):268-77. PubMed ID: 25600891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antileishmanial activity and trypanothione reductase effects of terpenes from the Amazonian species Croton cajucara Benth (Euphorbiaceae).
    Lima GS; Castro-Pinto DB; Machado GC; Maciel MA; Echevarria A
    Phytomedicine; 2015 Nov; 22(12):1133-7. PubMed ID: 26547537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of tamoxifen and miltefosine combined therapy for cutaneous leishmaniasis in the murine model of infection with Leishmania amazonensis.
    Trinconi CT; Reimão JQ; Coelho AC; Uliana SR
    J Antimicrob Chemother; 2016 May; 71(5):1314-22. PubMed ID: 26851606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo anti-parasitic activity of biogenic antimony sulfide nanoparticles on Leishmania major (MRHO/IR/75/ER).
    Mohtasebi S; Mohebali M; Elikaee S; Akhoundi B; Foroushani AR; Teimouri A; Yarizadeh H
    Parasitol Res; 2019 Sep; 118(9):2669-2678. PubMed ID: 31278518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial dysfunction on Leishmania (Leishmania) amazonensis induced by ketoconazole: insights into drug mode of action.
    Nunes DCOS; Costa MS; Bispo-da-Silva LB; Ferro EAV; Zóia MAP; Goulart LR; Rodrigues RS; Rodrigues VM; Yoneyama KAG
    Mem Inst Oswaldo Cruz; 2022; 117():e210157. PubMed ID: 35508030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of (-)α-bisabolol as a promising agent against Leishmania amazonensis.
    Rottini MM; Amaral AC; Ferreira JL; Silva JR; Taniwaki NN; Souza Cda S; d'Escoffier LN; Almeida-Souza F; Hardoim Dde J; Gonçalves da Costa SC; Calabrese Kda S
    Exp Parasitol; 2015 Jan; 148():66-72. PubMed ID: 25448354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of nicotinamide/antileishmanial drug combinations.
    Gazanion E; Vergnes B; Seveno M; Garcia D; Oury B; Ait-Oudhia K; Ouaissi A; Sereno D
    Parasitol Int; 2011 Jan; 60(1):19-24. PubMed ID: 20884376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The heat shock protein HSP70 and heat shock cognate protein HSC70 contribute to antimony tolerance in the protozoan parasite leishmania.
    Brochu C; Haimeur A; Ouellette M
    Cell Stress Chaperones; 2004; 9(3):294-303. PubMed ID: 15544167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-nitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin lesions.
    Costa IS; de Souza GF; de Oliveira MG; Abrahamsohn Ide A
    J Antimicrob Chemother; 2013 Nov; 68(11):2561-8. PubMed ID: 23788476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dilutions of antimony modulate cytokines production and macrophage - Leishmania (L.) amazonensis interaction in vitro.
    de Santana FR; Dalboni LC; Nascimento KF; Konno FT; Alvares-Saraiva AM; Correia MSF; Bomfim MDC; Casarin RCV; Perez EC; Lallo MA; Peres GB; Laurenti MD; Benites NR; Buchi DF; Bonamin LV
    Cytokine; 2017 Apr; 92():33-47. PubMed ID: 28092793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asiaticoside induces tumour-necrosis-factor-α-mediated nitric oxide production to cure experimental visceral leishmaniasis caused by antimony-susceptible and -resistant Leishmania donovani strains.
    Bhaumik SK; Paul J; Naskar K; Karmakar S; De T
    J Antimicrob Chemother; 2012 Apr; 67(4):910-20. PubMed ID: 22258930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of 2-nitrovinylfuran derivatives against Leishmania in vitro and in vivo.
    Sifontes-Rodríguez S; Monzote-Fidalgo L; Castañedo-Cancio N; Montalvo-Álvarez AM; López-Hernández Y; Diogo NM; Infante-Bourzac JF; Pérez-Martín O; Meneses-Marcel A; García-Trevijano JA; Cabrera-Pérez MÁ
    Mem Inst Oswaldo Cruz; 2015 Apr; 110(2):166-73. PubMed ID: 25946239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Efficacy of Apigenin against Cutaneous Leishmaniasis: Involvement of Reactive Oxygen Species and Autophagy as a Mechanism of Action.
    Fonseca-Silva F; Inacio JD; Canto-Cavalheiro MM; Menna-Barreto RF; Almeida-Amaral EE
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004442. PubMed ID: 26862901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.